September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Inhibition of choroidal neovascularization by local application of candesartan
Author Affiliations & Notes
  • Yoshitaka Okuda
    Osaka Medical College Hospital, Takatsuki, Japan
  • Masanori Fukumoto
    Osaka Medical College Hospital, Takatsuki, Japan
  • Taeko Horie
    Osaka Medical College Hospital, Takatsuki, Japan
  • Hidehiro Oku
    Osaka Medical College Hospital, Takatsuki, Japan
  • Seita Morishita
    Osaka Medical College Hospital, Takatsuki, Japan
  • Teruyo Kida
    Osaka Medical College Hospital, Takatsuki, Japan
  • Tsunehiko Ikeda
    Osaka Medical College Hospital, Takatsuki, Japan
  • Footnotes
    Commercial Relationships   Yoshitaka Okuda, None; Masanori Fukumoto, None; Taeko Horie, None; Hidehiro Oku, None; Seita Morishita, None; Teruyo Kida, None; Tsunehiko Ikeda, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1110. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Yoshitaka Okuda, Masanori Fukumoto, Taeko Horie, Hidehiro Oku, Seita Morishita, Teruyo Kida, Tsunehiko Ikeda; Inhibition of choroidal neovascularization by local application of candesartan. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1110.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : Inhibitory effect of systemic administration of candesartan(CAN), angiotensin receptor blocker on experimental choroidal neovascularization has been reported. The purpose of the present study is to examine the inhibitory effect of locally administered CAN on experimental choroidal neovascularization.

Methods : Laser photocoagulation was used to induce CNV in Brown Norway rat. The rats were pretreated with subconjunctival injection of CAN(1mg/kg) or PBS for 3 days before photocoagulation. The volume of CNV was evaluated 7days after laser injury by lectin staining technique. The infiltration of the macrophage within the CNV lesion was measured by immunofluorescent staining with anti-CD68 antibody. The mRNA expression levels of MCP-1, VEGF and IL1-β in retinal pigment epithelium were determined using real-time RT-PCR. All animal experiments were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Results : The index of CNV volume was significantly suppressed by treatment with CAN (48%) compared with that in vehicle-treated animals (p<0.05). The subconjunctival injection of CAN resulted in a reduction in number of CD68 positive cells in the CNV lesion.
The increase in mRNA levels of MCP-1, VEGF and IL1-β induced by photocoagulation was significantly suppressed by local administration of candesartan (p<0.05).

Conclusions : Local administration of candesartan, angiotensin receptor antagonists, inhibited the experimental CNV via anti-inflammatory effects. The present study suggests the possibility of locally administered candesartan as a therapeutic strategy to suppress CNV associated with AMD.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×